Literature DB >> 6769812

Fatal measles infection in marmosets pathogenesis and prophylaxis.

P Albrecht, D Lorenz, M J Klutch, J H Vickers, F A Ennis.   

Abstract

Moustached marmosets (Saguinus mystax) were infected intranasally with either of two low-passaged, wildlike strains of measles virus, strain Edmonston or strain JM. The infection resulted in 25 and 100% mortality, respectively, 12 to 14 days after infection. Clinical signs, gross pathological findings, and histology lacked the characteristic features of measles in other primates. A deficient immune response and widespread gastroenterocolitis appeared to be the main causes for the fatal outcome. Fluorescent-antibody staining detected large amounts of measles antigen in lymphatic tissues, the gastrointestinal and respiratory tracts, the salivary glands, pancreas, liver, kidney, and other visceral tissues. Live attenuated or inactivated measles vaccine proved equally effective in preventing fatal measles in marmosets. Challenge with live virus of animals which were primed 1 year previously with inactivated alum-absorbed vaccine resulted in a precipitous response, with a 100- to 1,000-fold increase in antibody titers. This vigorous booster response suggests the existence of a primary deficiency in lymphocyte cooperation in marmosets, which upon adequate priming is followed by extensive clonal expansion and antibody synthesis. Marmosets appear to be the most susceptible primate species to measles infection. They are capable of distinguishing differences in virulence of virus strains with a level of sensitivity not available in other animals.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6769812      PMCID: PMC550869          DOI: 10.1128/iai.27.3.969-978.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Measles: a protein-losing enteropathy.

Authors:  J H Axton
Journal:  Br Med J       Date:  1975-07-12

Review 2.  Elicitation of selective T and B lymphocyte responses by cell surface binding ligands.

Authors:  M Greaves; G Janossy
Journal:  Transplant Rev       Date:  1972

3.  An epizootic of measles in a marmoset colony.

Authors:  B M Levy; R R Mirkovic
Journal:  Lab Anim Sci       Date:  1971-02

4.  Measles as an index of immunological function.

Authors:  F M Burnet
Journal:  Lancet       Date:  1968-09-14       Impact factor: 79.321

5.  Severe measles in the tropics. I.

Authors:  D Morley
Journal:  Br Med J       Date:  1969-02-01

6.  Vaccine-induced hypersensitivity: reactions to live measles and mumps vaccine in prior recipients of inactivated measles vaccine.

Authors:  R W Harris; P Isacson; D T Karzon
Journal:  J Pediatr       Date:  1969-04       Impact factor: 4.406

7.  Transmission of kuru and Creutzfeldt-Jakob disease to marmoset monkeys.

Authors:  D A Peterson; L G Wolfe; F Deinhardt; D C Gajdusek; C J Gibbs
Journal:  Intervirology       Date:  1974       Impact factor: 1.763

8.  Pathology of measles in rhesus monkeys.

Authors:  W C Hall; R M Kovatch; P H Herman; J G Fox
Journal:  Vet Pathol       Date:  1971       Impact factor: 2.221

9.  Isolation of measles virus from cell cultures of brain from a patient with subacute sclerosing panencephalitis.

Authors:  F E Payne; J V Baublis; H H Itabashi
Journal:  N Engl J Med       Date:  1969-09-11       Impact factor: 91.245

10.  Immune responses during measles infection in immunosuppressed Rhesus monkeys.

Authors:  J T Hicks; J L Sullivan; P Albrecht
Journal:  J Immunol       Date:  1977-10       Impact factor: 5.422

View more
  26 in total

1.  Comparison of predicted amino acid sequences of measles virus strains in the Edmonston vaccine lineage.

Authors:  C L Parks; R A Lerch; P Walpita; H P Wang; M S Sidhu; S A Udem
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  Artificial mutations and natural variations in the CD46 molecules from human and monkey cells define regions important for measles virus binding.

Authors:  E C Hsu; R E Dörig; F Sarangi; A Marcil; C Iorio; C D Richardson
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  Multicenter Safety and Immunogenicity Trial of an Attenuated Measles Vaccine for NHP.

Authors:  Joann L Yee; Michael B McChesney; Kari L Christe
Journal:  Comp Med       Date:  2015-10       Impact factor: 0.982

Review 4.  Immune containment and consequences of measles virus infection in healthy and immunocompromised individuals.

Authors:  Sallie R Permar; Diane E Griffin; Norman L Letvin
Journal:  Clin Vaccine Immunol       Date:  2006-04

5.  Measles virus-induced immune suppression in the cotton rat (Sigmodon hispidus) model depends on viral glycoproteins.

Authors:  S Niewiesk; I Eisenhuth; A Fooks; J C Clegg; J J Schnorr; S Schneider-Schaulies; V ter Meulen
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

6.  Roles of macrophages in measles virus infection of genetically modified mice.

Authors:  B Roscic-Mrkic; R A Schwendener; B Odermatt; A Zuniga; J Pavlovic; M A Billeter; R Cattaneo
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

7.  Use of cotton rats to evaluate the efficacy of antivirals in treatment of measles virus infections.

Authors:  P R Wyde; D K Moore-Poveda; E De Clercq; J Neyts; A Matsuda; N Minakawa; E Guzman; B E Gilbert
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

8.  Differential downregulation of CD46 by measles virus strains.

Authors:  J Schneider-Schaulies; L M Dunster; F Kobune; B Rima; V ter Meulen
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Infection of marmosets with parainfluenza virus types 1 and 3.

Authors:  J D Hawthorne; D Lorenz; P Albrecht
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

10.  MiR-31 and miR-128 regulates poliovirus receptor-related 4 mediated measles virus infectivity in tumors.

Authors:  Hirosha Geekiyanage; Evanthia Galanis
Journal:  Mol Oncol       Date:  2016-07-28       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.